Takeshi Shoda

839 total citations
37 papers, 616 citations indexed

About

Takeshi Shoda is a scholar working on Pulmonary and Respiratory Medicine, Rheumatology and Epidemiology. According to data from OpenAlex, Takeshi Shoda has authored 37 papers receiving a total of 616 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Pulmonary and Respiratory Medicine, 18 papers in Rheumatology and 17 papers in Epidemiology. Recurrent topics in Takeshi Shoda's work include Inflammatory Myopathies and Dermatomyositis (15 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (14 papers) and Eosinophilic Disorders and Syndromes (12 papers). Takeshi Shoda is often cited by papers focused on Inflammatory Myopathies and Dermatomyositis (15 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (14 papers) and Eosinophilic Disorders and Syndromes (12 papers). Takeshi Shoda collaborates with scholars based in Japan and United States. Takeshi Shoda's co-authors include Tohru Takeuchi, Takuya Kotani, Shigeki Makino, Toshiaki Hanafusa, Shuzo Yoshida, Kenichiro Hata, Takaaki Ishida, Koji Nagai, Kentaro Isoda and Youhei Fujiki and has published in prestigious journals such as PLoS ONE, Macromolecules and Scientific Reports.

In The Last Decade

Takeshi Shoda

35 papers receiving 600 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Takeshi Shoda Japan	14	331	263	259	108	86	37	616
Bożena Targońska‐Stępniak Poland	12	126 0.4×	238 0.9×	52 0.2×	66 0.6×	50 0.6×	41	490
Chang Keun Lee South Korea	11	121 0.4×	150 0.6×	196 0.8×	109 1.0×	69 0.8×	13	469
P.V. Voulgari Greece	12	98 0.3×	279 1.1×	51 0.2×	85 0.8×	151 1.8×	29	539
Alexander Oldroyd United Kingdom	13	283 0.9×	126 0.5×	227 0.9×	56 0.5×	77 0.9×	25	583
C. Cazalets France	14	119 0.4×	36 0.1×	161 0.6×	50 0.5×	196 2.3×	38	445
Christian Massot France	10	83 0.3×	166 0.6×	77 0.3×	87 0.8×	128 1.5×	32	549
Anthony G. DiBartolomeo United States	9	96 0.3×	202 0.8×	90 0.3×	36 0.3×	58 0.7×	16	401
C Danese Italy	14	79 0.2×	104 0.4×	53 0.2×	94 0.9×	192 2.2×	31	597
Kohei Ikezoe Japan	15	131 0.4×	89 0.3×	538 2.1×	22 0.2×	46 0.5×	45	701
In Ah Choi South Korea	14	91 0.3×	330 1.3×	32 0.1×	109 1.0×	60 0.7×	46	598

Countries citing papers authored by Takeshi Shoda

Since Specialization

Citations

This map shows the geographic impact of Takeshi Shoda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takeshi Shoda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takeshi Shoda more than expected).

Fields of papers citing papers by Takeshi Shoda

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takeshi Shoda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takeshi Shoda. The network helps show where Takeshi Shoda may publish in the future.

Co-authorship network of co-authors of Takeshi Shoda

This figure shows the co-authorship network connecting the top 25 collaborators of Takeshi Shoda. A scholar is included among the top collaborators of Takeshi Shoda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takeshi Shoda. Takeshi Shoda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kotani, Takuya, et al.. (2024). Poor prognostic factors for relapse of interstitial lung disease with anti-aminoacyl-tRNA synthetase antibodies after combination therapy. Frontiers in Immunology. 15. 1407633–1407633.

Shoda, Takeshi, Takuya Kotani, Mitsuhiro Koyama, et al.. (2024). The Therapeutic Efficacy of Abatacept for Rheumatoid Arthritis-Associated Interstitial Lung Disease: Insights from a 12-Month Trial Using Semi-Quantitative Chest High-Resolution Computed Tomography Imaging. Journal of Clinical Medicine. 13(19). 5871–5871. 3 indexed citations

Hata, Kenichiro, Takuya Kotani, Youhei Fujiki, et al.. (2023). Aggressive multi‐combination therapy for anti‐MDA5 antibody‐positive dermatomyositis‐rapidly progressive interstitial lung disease. International Journal of Rheumatic Diseases. 27(1). e14999–e14999. 3 indexed citations

Kotani, Takuya, Yumiko Wada, Hideyuki Shiba, et al.. (2023). Serum Complement C4 Levels Are a Useful Biomarker for Predicting End-Stage Renal Disease in Microscopic Polyangiitis. International Journal of Molecular Sciences. 24(19). 14436–14436. 7 indexed citations

Kotani, Takuya, Hiroko Kuwabara, Hideyuki Shiba, et al.. (2022). Examination of nailfold videocapillaroscopy findings in ANCA-associated vasculitis. Lara D. Veeken. 62(2). 747–757. 8 indexed citations

Kotani, Takuya, Hiroko Kuwabara, Takaaki Ishida, et al.. (2022). Association of M2 Macrophages, Th2, and B Cells With Pathomechanism in Microscopic Polyangiitis Complicated by Interstitial Lung Disease. The Journal of Rheumatology. 49(8). 913–921. 6 indexed citations

Kotani, Takuya, Keisuke Fukui, Takaaki Ishida, et al.. (2021). Evaluation of poor prognostic factors of respiratory related death in microscopic polyangiitis complicated by interstitial lung disease. Scientific Reports. 11(1). 1490–1490. 18 indexed citations

Kotani, Takuya, et al.. (2020). The comparison of nailfold videocapillaroscopy findings between anti-melanoma differentiation-associated gene 5 antibody and anti-aminoacyl tRNA synthetase antibody in patients with dermatomyositis complicated by interstitial lung disease. Scientific Reports. 10(1). 15692–15692. 15 indexed citations

Kotani, Takuya, Takaaki Ishida, Keisuke Fukui, et al.. (2019). Exploration of pathomechanism using comprehensive analysis of serum cytokines in polymyositis/dermatomyositis-interstitial lung disease. Lara D. Veeken. 59(2). 310–318. 32 indexed citations

10.

Kotani, Takuya, Takeshi Shoda, Youhei Fujiki, et al.. (2018). Efficacy and safety of combination therapy with prednisolone and oral tacrolimus for progressive interstitial pneumonia with systemic sclerosis: A retrospective study. Modern Rheumatology. 28(6). 1009–1015. 11 indexed citations

11.

Isoda, Kentaro, Takuya Kotani, Tohru Takeuchi, et al.. (2017). Comparison of long-term prognosis and relapse of dermatomyositis complicated with interstitial pneumonia according to autoantibodies: anti-aminoacyl tRNA synthetase antibodies versus anti-melanoma differentiation-associated gene 5 antibody. Rheumatology International. 37(8). 1335–1340. 33 indexed citations

12.

Kotani, Takuya, Tohru Takeuchi, Takaaki Ishida, et al.. (2017). Chemokine profiles of interstitial pneumonia in patients with dermatomyositis: a case control study. Scientific Reports. 7(1). 1635–1635. 25 indexed citations

13.

Isoda, Kentaro, et al.. (2017). Granulomatosis with Polyangiitis Complicated with Gastrointestinal Perforation: A Case Report and Review of Literature. Japanese Journal of Clinical Immunology. 40(5). 382–386. 3 indexed citations

14.

Isoda, Kentaro, Tohru Takeuchi, Takuya Kotani, et al.. (2014). Pre-Treatment Ferritin Level and Alveolar-Arterial Oxygen Gradient Can Predict Mortality Rate Due to Acute/Subacute Interstitial Pneumonia in Dermatomyositis Treated by Cyclosporine A/Glucocorticosteroid Combination Therapy: A Case Control Study. PLoS ONE. 9(2). e89610–e89610. 37 indexed citations

15.

Yoshida, Shuzo, Tohru Takeuchi, Takuya Kotani, et al.. (2013). Infliximab, a TNF-α inhibitor, reduces 24-h ambulatory blood pressure in rheumatoid arthritis patients. Journal of Human Hypertension. 28(3). 165–169. 74 indexed citations

16.

Kotani, Takuya, Tohru Takeuchi, Shigeki Makino, et al.. (2011). Combination with corticosteroids and cyclosporin-A improves pulmonary function test results and chest HRCT findings in dermatomyositis patients with acute/subacute interstitial pneumonia. Clinical Rheumatology. 30(8). 1021–1028. 62 indexed citations

17.

Kotani, Takuya, et al.. (2010). A refractory case of MPO-ANCA-associated vasculitis presented with gastrointestinal ulcer, rapidly progressive glomerular nephritis and pulmonary multiple nodules.. Japanese Journal of Clinical Immunology. 33(1). 31–36. 1 indexed citations

18.

Yoshida, Shuzo, Takuya Kotani, Tohru Takeuchi, et al.. (2008). Successful treatment of early intervention with tacrolimus for a patient with lupus nephritis III+V.. Japanese Journal of Clinical Immunology. 31(6). 460–464. 3 indexed citations

19.

Kotani, Takuya, et al.. (2007). A patient with interstitial pneumonia associated with dermatomyositis who relapsed after reducing cyclosporin-A treatment. Japanese Journal of Clinical Immunology. 30(2). 139–143. 1 indexed citations

20.

Sato, Takahiro, Takeshi Shoda, & Akio Teŕamoto. (1994). Scaled particle theory for wormlike hard spherocylinders: calculation of phase diagrams for ternary systems consisting of two semiflexible polymers with different lengths and a solvent. Macromolecules. 27(1). 164–170. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact